4.6 Article

MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity

Yingming Sun et al.

Summary: MUC3A is highly expressed in non-small cell lung cancer (NSCLC) and associated with poor prognosis, advanced staging, and low differentiation. Knockdown of MUC3A suppresses tumor growth and DNA damage repair pathways, suggesting it may be a potential oncogene.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer

Yuan Luo et al.

Summary: The transmembrane mucin MUC3A induces PD-L1 expression in NSCLC, promoting immune escape, while downregulation of MUC3A enhances the effects of TKIs in EGFR-mutant NSCLC. Knocking down MUC3A reduces PD-L1 expression by downregulating the activation of the PI3K/Akt and MAPK pathways. In vitro, the combination of MUC3A knockdown and TKIs in EGFR-mutant NSCLC cells has a synergistic effect on inhibiting proliferation and promoting apoptosis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the potent antigenic targets for CAR T cell therapy of gastric adenocarcinoma

Masoud Sotoudeh et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Oncology

Targeting mTOR for cancer therapy

Hui Hua et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

Ali S. Alzahrani

SEMINARS IN CANCER BIOLOGY (2019)

Review Oncology

mTOR: Role in cancer, metastasis and drug resistance

Avaniyapuram Kannan Murugan

SEMINARS IN CANCER BIOLOGY (2019)

Article Gastroenterology & Hepatology

Advances in CRC Prevention: Screening and Surveillance

Evelien Dekker et al.

GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Lifestyle Risk Factors for Serrated Colorectal Polyps: A Systematic Review and Meta-analysis

Lesley Bailie et al.

GASTROENTEROLOGY (2017)

Editorial Material Multidisciplinary Sciences

Colorectal cancer

Herb Brody

NATURE (2015)

Review Biotechnology & Applied Microbiology

Rapamycin passes the torch: a new generation of mTOR inhibitors

Don Benjamin et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Endocrinology & Metabolism

Glycogen Synthase Kinase-3 Plays a Central Role in Mediating Glucocorticoid-Induced Apoptosis

Rachel Spokoini et al.

MOLECULAR ENDOCRINOLOGY (2010)

Article Oncology

DNA methyltransferase and alcohol dehydrogenase: Gene-nutrient interactions in relation to risk of colorectal polyps

Audrey Y. Jung et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)

Review Oncology

Mucins and mucin binding proteins in colorectal cancer

JC Byrd et al.

CANCER AND METASTASIS REVIEWS (2004)